21
758 forecasters
Will the US, UK or EU approve a gene editing therapy for a new condition during 2026?
20%chance
Top Key Factors
World’s first patient treated with personalized CRISPR gene editing therapy through CHOP and Penn Med collaboration | Penn Todaypenntoday.upenn.edu•May 15, 2025
Increases Likelihood
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Diseasefda.gov•Jan 12, 2026
Increases Likelihood
World’s first patient treated with personalized CRISPR gene editing therapy through CHOP and Penn Med collaboration | Penn Todaypenntoday.upenn.edu•May 15, 2025
Increases Likelihood
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Diseasefda.gov•Jan 12, 2026
Increases Likelihood